Joint morphogenetic cells in the adult mammalian synovium by Roelofs, Anke J et al.
ARTICLE
Received 28 Jul 2016 | Accepted 17 Feb 2017 | Published 16 May 2017
Joint morphogenetic cells in the adult
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Anke J. Roelofs1,*, Janja Zupan1,*, Anna H.K. Riemen1, Karolina Kania1, Sharon Ansboro1, Nathan White1,
Susan M. Clark1 & Cosimo De Bari1
The stem cells that safeguard synovial joints in adulthood are undeﬁned. Studies on
mesenchymal stromal/stem cells (MSCs) have mainly focused on bone marrow. Here we
show that lineage tracing of Gdf5-expressing joint interzone cells identiﬁes in adult mouse
synovium an MSC population largely negative for the skeletal stem cell markers Nestin-GFP,
Leptin receptor and Gremlin1. Following cartilage injury, Gdf5-lineage cells underpin synovial
hyperplasia through proliferation, are recruited to a Nestin-GFPhigh perivascular population,
and contribute to cartilage repair. The transcriptional co-factor Yap is upregulated after injury,
and its conditional ablation in Gdf5-lineage cells prevents synovial lining hyperplasia and
decreases contribution of Gdf5-lineage cells to cartilage repair. Cultured Gdf5-lineage
cells exhibit progenitor activity for stable chondrocytes and are able to self-organize
three-dimensionally to form a synovial lining-like layer. Finally, human synovial MSCs
transduced with Bmp7 display morphogenetic properties by patterning a joint-like organ
in vivo. Our ﬁndings further the understanding of the skeletal stem/progenitor cells in
adult life.
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T
he stem and progenitor cells that maintain and repair adult
joint tissues, including articular cartilage, remain
undeﬁned. Cells that display mesenchymal stromal/stem
cell (MSC) activity in vitro (that is, clonogenicity and
multipotency) have been isolated from adult skeletal tissues
including synovium1,2 and bone marrow3. Recent efforts have
focused on identifying skeletal stem cells in bone marrow in situ
and understanding their contributions to bone homoeostasis and
repair. In mouse bone marrow, perivascular MSCs are marked by
Pdgfra and Sca1 (refs 4,5), Nestin (Nes)-GFP6,7 and Leptin
receptor (LepR)8–10, with at least partial overlap between these
populations. They support haematopoiesis and are an important
source of osteogenic and adipogenic lineages in adult marrow6,10.
In addition, Worthley et al.11 identiﬁed a population of
osteochondroreticular (OCR) stem cells marked by expression
of Gremlin (Grem)1, which are distinct from Nestin-Green
Fluorescent Protein (Nes-GFP)þ cells, and contribute to early
postnatal growing bones and fracture repair in adult mice. In
contrast to the signiﬁcant advances in our understanding of the
MSC populations in bone marrow, little is known about the
MSCs that are resident in the synovial joint and their roles in the
maintenance and repair of articular cartilage which, as opposed to
the transient cartilage of the growth plate and fracture callus that
undergo endochondral ossiﬁcation, is stable throughout life.
The synovium is a thin membrane that lines the inside of
synovial joints. It consists of a lining layer of macrophage-like
synoviocytes and ﬁbroblast-like synoviocytes (FLS), and
a sub-lining vascularized connective tissue. Using a double-
nucleoside-analogue labelling method, we showed the presence of
label-retaining cells in synovium with an MSC phenotype12.
The origins of these cells in synovium and their relationship
with the MSC populations as described in bone marrow remain
to be elucidated.
During embryonic life, condensation of mesenchymal cells
leads to the formation of the cartilage template in the developing
limb. In the region of a prospective synovial joint, a stripe of
mesenchymal tissue forms the joint interzone (JI), which is
marked by expression of a number of genes, including growth
and differentiation factor 5 (Gdf5)13. In Gdf5-Cre;LacZ mice,
Cre-induced expression of LacZ is detectable in nearly all JI cells
of the prospective knee at E14.5 (ref. 14) and is seen in tissues of
postnatal synovial joints14,15. Here we sought to determine the
location, phenotype and function of Gdf5-expressing JI progeny
in the adult knee, hypothesizing that they represent an
ontogenetically deﬁned population containing stem/progenitor
cells that play important roles in joint homoeostasis and repair.
Our ﬁndings show that Gdf5-lineage cells in mice persist in the
adult synovium as MSCs with joint progenitor activity that after
injury, in a Yes-associated protein (Yap)-dependent manner,
proliferate to underpin synovial lining hyperplasia and contribute
to cartilage repair. We further show that adult human synovial
MSCs display joint morphogenetic properties in vivo. Together,
our ﬁndings indicate that the synovium is a postnatal reservoir
of MSCs that descend from the embryonic JI and maintain
joint tissues in adult life.
Results
Gdf5-lineage cells persist as MSCs in adult synovium. To trace
cells of the embryonic JI, Gdf5-Cre mice were crossed with
tdTomato (Tom) ﬂuorescent reporter mice. In the Gdf5-Cre
model, Cre-mediated recombination in the limbs is restricted to
JI cells14,15. Mice with leaky, widespread Cre expression14 were
prospectively identiﬁed (Supplementary Fig. 1a–c). In adult knee
joints, Tomþ cells were present in articular cartilage, menisci,
ligaments (Fig. 1a), epiphyses (Fig. 1b), synovium (Fig. 1c) and fat
pad (Supplementary Fig. 1d). They included osteocytes (Fig. 1b)
and osteocalcinþ osteoblasts (Supplementary Fig. 1e) in
subchondral bone, but were rare in metaphyses or diaphyses
(Fig. 1a and Supplementary Fig. 1f).
Tomþ cells persisted in synovium up to at least 1 year of age
(Fig. 1d). They were most abundant in synovial lining, but also
included a small population of cells in the vascularized sub-lining
connective tissue (Fig. 1e). Tomþ cells expressed the
pan-ﬁbroblast/MSC marker Pdgfra (Fig. 1f), and were distinct
from CD16/CD32þ macrophages (Fig. 1g) or CD31þ endothe-
lium (Fig. 1h). Lubricin (or Proteoglycan 4, Prg4) was expressed
by both Tomþ and Tom cells in synovial lining, while
undetectable in Tomþ cells in sub-lining (Fig. 1i). Phenotyping
by ﬂow cytometry (Supplementary Fig. 2a–c) conﬁrmed
Tomþ cells to be negative for CD45, CD11b, CD16/CD32 and
CD31, while they heterogeneously expressed MSC/ﬁbroblast
markers, including Pdgfra, Sca1, gp38, CD73, CD200, Thy1.1
(CD90), CD105 and alphaV (CD51) (Fig. 1j and Supplementary
Fig. 2d). Similar results were obtained at B1 year of age
(Supplementary Fig. 2e,f).
Sorting of freshly isolated cells for Tom and Pdgfra expression
within the CD45 stromal fraction (Supplementary Fig. 3a,b)
showed Tomþ and TomPdgfraþ populations to be enriched
in colony-forming unit ﬁbroblast (CFU-f) activity compared to
TomPdgfra stromal cells (Fig. 1k and Supplementary
Fig. 3c,d), and the latter failed to expand beyond p2.
Correlating Tom, Gdf5 and Cre mRNA expression in
embryonic limbs, adult knee soft tissues, and Tomþ and Tom
sorted and culture-expanded cells (Supplementary Fig. 4)
supported the notion that Tom expression in this model indicates
derivation from the embryonic JI. Taken together, these ﬁndings
show Gdf5-lineage cells to be major contributors to the
clonogenic stromal cell populations in adult synovium.
Relationship with previously identiﬁed skeletal stem cells. The
presence of Tomþ cells near CD31þ blood vessels in the vascu-
larized synovial sub-lining (Fig. 1h) raised the possibility that the
Gdf5 lineage may include perivascular MSCs marked by Nes-GFP6,7
or LepR expression8–10. In E14.5 Gdf5-Cre;Tom;Nes-GFP embryo
hindlimbs, Nes-GFPþ cells were found along the perichondrium
(Fig. 1l) as reported16. They were ﬂanking the JI region of the
prospective knee where they co-localized with CD31 expression, but
were distinct from Tomþ JI cells (Fig. 1l,m). In adult synovium, a
small population of Nes-GFPþ cells was detected in the
vascularized sub-lining tissue frequently associated with CD31þ
blood vessels that showed little overlap with Tomþ cells (Figs 1m
and 3a). Similarly, very few LepR-expressing cells were present
within the Gdf5-lineage population (Fig. 1n). In bone marrow, an
MSC population distinct from Nes-GFPþ cells is identiﬁed by
expression of Grem1 (ref. 11). Immunostaining revealed rare
Grem1þ cells located in the sub-lining synovial tissue, but no
overlap was detected with Gdf5-lineage cells (Fig. 1o). These
ﬁndings indicate that the Gdf5 lineage in adult synovium is largely
distinct from known skeletal stem/progenitor cell populations as
described in bone marrow.
Gdf5-lineage cells in synovium proliferate after injury. Injury of
the articular cartilage induces synovial hyperplasia, which we
have shown to involve proliferation of MSCs12,17. We thus
assessed the response of Gdf5-lineage cells in synovium to
cartilage injury (Fig. 2a). Six days after injury, the hyperplastic
synovium at the femoropatellar junction, near the cartilage defect,
showed an increase in the percentage of cells that were Tomþ
(Fig. 2b,c; 61.7±2.2% (mean±s.d., n¼ 4) in injured versus
32.4±5.8% (mean±s.d., n¼ 4) in control). This was not due to
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Figure 1 | Gdf5-lineage cells in the mouse knee. (a–c) Tom ﬂuorescence (red) in adult Gdf5-Cre;Tom mice showing (a) low magniﬁcation overview of knee
(n¼ 3), (b) epiphyseal bone with arrows indicating Tomþ osteocytes (n¼ 3), (c) synovium (n¼6). Nuclei were counterstained with DAPI (blue).
(d,e) Tomþ cells in (d) synovium at different ages (n¼4-6), and (e) adult synovial lining and sub-lining (n¼ 6), as percentage of DAPIþ cells. (f–i) Tomþ
cells (red) in synovium (f) express the MSC/ﬁbroblast marker Pdgfra (green; n¼4), are distinct from (g) CD16/CD32þ (green) macrophages (n¼4) and
(h) CD31þ (green) endothelial cells (n¼ 3), and (i) express lubricin (Lubr; green) in lining (arrowheads) but not sub-lining (arrows) (n¼4). Nuclei were
counterstained with DAPI (blue). (j) Cell surface phenotype determined by ﬂow cytometry (n¼ 3–18; pooled data from seven experiments). See also
Supplementary Fig. 2. (k) CFU-f activity of cells sorted by FACS. Colonies ofZ32 cells (Z5 population doublings) were counted (see also Supplementary
Fig. 3). Tomþ and Tom-Pdgfraþ populations were enriched for CFU-f activity (**Po0.01; n¼ 3; one-way ANOVA with Bonferroni post-test). (l) Tom (red)
and GFP (green) ﬂuorescence in hindlimb from Gdf5-Cre;Tom;Nes-GFP E14.5 embryo (n¼4), showing Nes-GFPþ cells associated with CD31 staining
(white) distinct from Tomþ JI cells. Nuclei were counterstained with DAPI (blue). (m) Flow cytometry showing limited overlap between Nes-GFPþ cells
and Tomþ Gdf5 lineage in E14.5 hindlimb (n¼ 3) and adult knee synovium of Gdf5-Cre;Tom;Nes-GFP mice (n¼ 5). (n) LepR expression detected using a
pan-LepR antibody showing very few LepRþ cells within the Tomþ Gdf5 lineage (n¼ 5). (o) Grem1 (green) and Tom (red) expression in adult Gdf5-Cre;Tom
mouse synovium (n¼4) detected by IF staining failing to show overlap. Nuclei were counterstained with DAPI (blue). P, patella; F, femur; T, tibia;
S, synovium; L, synovial lining; SL, synovial sub-lining; C, capsule; B, bone; M, marrow; AC, articular cartilage; JI, joint interzone. Scale bars, 200mm
(a) and 20mm (b,c,f–i,l,o).
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de novo induction of Gdf5 or Cre expression (Supplementary
Fig. 4), and phenotyping conﬁrmed that Tomþ cells remained
distinct from CD16/CD32þ haematopoietic and CD31þ
endothelial cells (Fig. 2d). Instead, the relative expansion of the
Tomþ population was likely the result of a high proliferative
response to injury, as assessed by chlorodeoxyuridine (CldU)
labelling (Fig. 2b,e; 69.0±2.7% (mean±s.d., n¼ 4) of Tomþ
versus 33.1±5.4% (mean±s.d., n¼ 4) of Tom cells were
CldUþ ). Immunoﬂuorescence (IF) staining for iododeoxyuridine
(IdU) (marking label-retaining cells), CldU (marking cells
proliferating after injury) and Tom revealed the presence of
triple-positive cells in the hyperplastic synovium (Fig. 2f),
indicating that the Gdf5 lineage contained label-retaining
(quiescent) cells that had re-entered the cell cycle in response
to injury, a functional feature of stem cells postnatally18.
To determine the contribution of perivascular MSCs to
synovial hyperplasia, we analysed LepR-Cre;Tom mice. Similar
to Nes-GFPþ cells, the LepR lineage constituted a small
population in the synovial sub-lining associated with CD31þ
blood vessels (Fig. 2g). In contrast to the Gdf5 lineage, the
LepR-traced population in synovium did not expand in response
to injury (Fig. 2g,h).
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Figure 2 | Contribution of Gdf5 lineage to synovial hyperplasia after cartilage injury. (a) Schematic experimental design for data in b–f.
(b) IF staining for Tom (red) and CldU (green) in control and injured knee synovium. Nuclei were counterstained with DAPI (blue). (c) Tomþ cells, as
percentage of total cells in synovium as shown in b, increased after injury (***Po0.0001; n¼4; Student’s t-test). (d) Tomþ (red) cells in injured knee
synovium negative for the haematopoietic marker CD16/CD32 (green; n¼ 3; image on left) and endothelial marker CD31 (green; n¼4; image on right).
Nuclei were counterstained with DAPI (blue). (e) CldU-labelling showing higher rate of proliferation in Tomþ compared to Tom cells after injury
(***Po0.0001; n¼4; two-way ANOVA with Bonferroni post-test). (f) IF staining for IdU (red), CldU (green) and Tom (blue) in injured knee synovium
(n¼ 3). Nuclei were counterstained with DAPI (grey). Left: IdU and CldU overlaid; right: all channels overlaid. Arrows indicate triple-labelled cells.
(g) Tomþ (red) cells in control and injured knee synovium of adult LepR-Cre;Tom mice (n¼4) with CD31 in green. Nuclei were counterstained with DAPI
(blue). (h) Tomþ cells in synovium as percentage of total cells. Dashed lines, synovial boundary; S, synovium; P, patella; F, femur; C, capsule. Scale bars,
20mm. Data in b,c,e are representative of two experiments.
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Taken together, these data demonstrate that MSCs in
synovium that are quiescent and proliferate in response to injury
of the articular cartilage are contained for a large part within the
Gdf5 lineage.
Recruitment into Nes-GFPþ perivascular cells after injury.
Next, we used Gdf5-Cre;Tom;Nes-GFP mice to further investigate
the relationship between perivascular cells and the Gdf5 lineage in
synovium following cartilage injury. The percentage of Nes-GFP
single-positive cells in synovium did not change (Fig. 3a,b),
suggesting a limited response of these cells to cartilage injury,
similar to the LepR lineage (Fig. 2g,h). In contrast, the
Nes-GFPþTomþ population expanded (Fig. 3a,b; 0.9±0.1%
(mean±s.d., n¼ 4) of total cells in injured versus 0.3±0.2%
(mean±s.d., n¼ 4) in control). Nes-GFPþTomþ cells were
located in the sub-lining and were almost exclusively perivascular
(Fig. 3a and Supplementary Fig. 5a). While the density of
Nes-GFP single-positive cells surrounding blood vessels remained
stable after injury, vascular density of Nes-GFPþTomþ cells
increased (Fig. 3c and Supplementary Fig. 5b,c; 4.4±1.1
(mean±s.d., n¼ 4) cells per mm vasculature in injured versus
1.8±1.1 (mean±s.d., n¼ 4) in control). Flow cytometry revealed
Nes-GFPþTomþ cells in injured knees to be mostly contained
within the Nes-GFPbright fraction (Fig. 3d), and conﬁrmed
this population to be increased in response to cartilage injury
relative to both Tomþ (Fig. 3e; 5.9±3.8% (mean±s.d., n¼ 12)
of Tomþ cells were Nes-GFPbright in injured versus 0.9±1.4%
(mean±s.d., n¼ 12) in control) and Nes-GFPbright populations
(Fig. 3f; 25.8±13.4% (mean±s.d., n¼ 12) of Nes-GFPbright cells
were Tomþ in injured versus 9.1±12.1% (mean±s.d., n¼ 12) in
control). Marker analyses showed that the Nes-GFPbrightTomþ
cells were PdgfraSca1CD105þCD31LepR (Fig. 3g,h),
phenotypically similar to the Nes-GFPbright single-positive cells,
but distinct from the bulk of the Gdf5-lineage population that
were PdgfraþSca1þ , or the Nes-GFPdim population, which
included subpopulations of PdgfraþSca1þ cells, LepRþ cells
and CD31þCD105þ endothelial cells (Fig. 3g,h).
These ﬁndings were suggestive of a recruitment of Gdf5-lineage
cells into a Nes-GFPbright population, described to localize around
arterioles in bone marrow19. Staining of adjacent sections
with either the pan-endothelial marker CD31, or SM22, a marker
of vascular smooth muscle surrounding arterioles (Fig. 3i and
Supplementary Fig. 5d), revealed a predominant localization of
Nes-GFPþTomþ cells with a Nes-GFPbright appearance tightly
packed around arterioles. Interestingly, Nes-GFPþTomþ cells
themselves were frequently SM22þ , suggesting differentiation into
smooth muscle cells.
Using an in vitro angiogenesis co-culture assay, we observed
culture-expanded Tomþ cells from Gdf5-Cre;Tom;Nes-GFP mice
to give rise to Nes-GFPþTomþ cells when co-cultured with
sprouting mouse aortic rings (AR) (Fig. 3j), while no Nes-GFP-
expressing cells were detected in wells without ARs.
Taken together, these ﬁndings show an injury-induced
recruitment of Gdf5-lineage cells into a Nes-GFPbrightPdgfra
Sca1CD105þCD31LepR population that is predominantly
periarteriolar and includes SM22þ smooth muscle cells.
Gdf5-lineage hyperplasia in synovium is Yap dependent. We
next sought to conﬁrm a crucial role for Gdf5-lineage cells in
synovial hyperplasia induced by cartilage damage, and to identify
the molecular mechanism underpinning this process. Forced
expression of a constitutively active form of the transcriptional
co-factor Yap increased proliferation of MSCs in vitro20. Here we
found Yap to be upregulated and prominently nuclear (active) in
the hyperplastic synovium of injured mouse knees (Fig. 4a). For
clinical relevance, we analysed synovium from patients with
intra-articular fracture or osteoarthritis. Irrespective of
underlying pathology, nuclear (active) YAP was detected in
areas of synovial lining with an activated, hyperplastic
appearance, while YAP was barely detected in non-hyperplastic
synovial lining within the same histological sections (Fig. 4b,c), or
in normal knee joint synovium (Fig. 4d). YAP co-localized
with the proliferation marker Ki67 (Fig. 4e) and CD55 (Fig. 4f),
a marker of FLS in human synovial lining21, while barely
detectable in CD68þ macrophages (Fig. 4f).
We therefore generated Gdf5-Cre;Yap1ﬂ/ﬂ;Tom mice in
which Yap1 is knocked out in Gdf5-lineage cells marked
by Tom expression (Yap1 cKO mice), and compared them to
Gdf5-Cre;Yap1ﬂ/WT;Tom haploinsufﬁcient (Yap1 cHa) mice and
Gdf5-Cre;Tom controls. Yap1 cKO mice were born at expected
Mendelian frequencies, and were phenotypically normal with no
obvious skeletal phenotype (Fig. 5a and Supplementary Fig. 6),
indicating that Yap1 expression by Gdf5-lineage cells is
dispensable for joint development and homoeostasis. KO of
Yap1 in the Gdf5 lineage was conﬁrmed by IF staining of synovial
cell cultures showing lack of Yap expression in Tomþ cells
(Fig. 5b). Yap1 cKO did not affect the rate of colony formation
in vitro (Fig. 5c); however, the proportion of large Tomþ
colonies was decreased, even from Yap1 cHa mice, while the
size of Tom colonies was not affected (Fig. 5d).
Analysis of mice after cartilage injury revealed that
the increased cellularity of synovial lining was prevented in
Yap1 cKO mice (Fig. 5e,f; 18.0±10.3 (mean±s.d., n¼ 4) average
cells/section in Yap1 cKO mice versus 85.9±28.1 (mean±s.d.,
n¼ 6) in controls). Strikingly, even Yap1 cHa mice showed
a decrease in cellularity of the lining compared to controls
(Fig. 5e,f; 43.7±22.8 (mean±s.d., n¼ 6) average cells
per section). In contrast, cellularity of the sub-lining, in which
only a minority of cells are of Gdf5 lineage (Fig. 1e), was not
affected in either the Yap1 cHa or Yap1 cKO mice (Fig. 5e,g).
Consistent with these ﬁndings, expansion of the Tomþ Gdf5
lineage in synovium following cartilage injury was diminished in
Yap1 cKO mice (Fig. 5e,h).
Altogether, these data point to Yap as a critical rate-limiting
factor in the process of hyperplasia of the synovial lining that is
driven by the Gdf5 lineage.
Gdf5-lineage cells give rise to new cartilage after injury. We
next focussed on the question whether adult Gdf5-lineage cells
retain the ability, from embryonic development, to give rise to
new cartilage. We injured Gdf5-Cre;Tom mice (which are on a
mixed FVB and C57Bl/6 background) and analysed the cartilage
repair tissue after 8–10 weeks (Fig. 6a). Four out of 12 injured
knees exhibited a cartilage-like repair tissue that contained cells
with chondrocyte morphology surrounded by a pericellular
matrix staining for safranin O and collagen type II (Col2)
(Fig. 6b), while the other knees contained a partial, ﬁbrous-like
repair tissue (Supplementary Fig. 7a). The majority of cells in
the cartilage-like repair tissue were Tomþ (Fig. 6b), though
occasional clusters of Tom chondrocytes were observed
(Supplementary Fig. 7b). Knees with poor healing contained
a lower percentage of Tomþ cells in the repair tissue (Fig. 6c;
78.8±6.4% (mean±s.d., n¼ 4) in good versus 46.6±14.5%
(mean±s.d., n¼ 8) in poor repair tissue). The cartilage-like
repair tissue, but not the surrounding cartilage, contained Tomþ
chondrocytes that had incorporated and retained the nucleoside
analogue CldU given for 12 days after injury (Fig. 6b), indicating
cells had undergone transient proliferation following injury.
We also analysed seven areas of ectopic cartilage that had
formed within the synovium not in direct continuum with the
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Figure 3 | Gdf5-lineage recruitment into a Nes-GFPbright perivascular population in response to injury. (a) Tomþ Gdf5-lineage (red) and Nes-GFPþ cells
(green) in control and injured knee synovium from adult Gdf5-Cre;Tom;Nes-GFP mice with CD31 in blue (n¼4). Arrows, Nes-GFPþ cells; arrowheads,
TomþNes-GFPþ cells; dashed lines, synovial boundary; S, synovium; C, capsule; P, patella; F, femur. Scale bars, 50mm. (b) Percentage of cells in synovium
that were TomþNes-GFPþ increased after injury (**P¼0.0016; n¼4; Student’s t-test). (c) TomþNes-GFPþ perivascular cell number increased relative to
the vasculature after injury (see also Supplementary Fig. 5a–c) (*P¼0.0154; n¼4; Student’s t-test). (d) Double-labelled cells in injured knee synovium
were mostly Nes-GFPbright. Equal total number of events is shown. (e,f) TomþNes-GFPbright cells, quantiﬁed from d, increased after injury as percentage of
(e) total Tomþ (***P¼0.0002; n¼ 12; Mann–Whitney test; pooled data from three experiments) and (f) total Nes-GFPbright cells (**P¼0.0060; n¼ 12;
Mann–Whitney test; pooled data from three experiments). (g) Phenotypic analysis of labelled cells from injured knees showing similarity between
TomþNes-GFPbright and Tom-Nes-GFPbright populations. For each population, equal number of events is shown. FSC, forward scatter. (h) Percentage of cells
within the indicated populations that were positive for the indicated marker(s) (n¼ 3–4; data from two experiments). (i) Adjacent histological sections
stained with CD31 (blue; left) or SM22 (blue; right) showing Tomþ (red) and Nes-GFPþ (green) double-positive cells (appearing yellow) in injured knee
synovium localizing predominantly around arterioles and expressing the smooth muscle marker SM22 (arrowheads) with some TomþNes-GFPþ cells
found around other CD31þ vessels (arrows) (n¼4). Nuclei were counterstained with DAPI (blue). Scale bars, 20mm. See also Supplementary Fig. 5d.
(j) Mouse AR co-cultured with Tomþ synovial cells from Gdf5-Cre;Tom;Nes-GFP mouse showing Tomþ (red) and Nes-GFPþ (green) double-positive
cell (appearing yellow; arrowhead) in close proximity to endothelial tubules (arrow). Nuclei were counterstained with DAPI (blue). n¼ 8 replicate
AR co-cultures. Left, middle: Phase-contrast only; box on left indicates region shown at higher magniﬁcation in middle. Scale bars, 200mm. Right:
Phase-contrast with ﬂuorescence overlaid. Scale bar, 50mm.
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joint surface12. Tomþ cells with morphology of chondrocytes
were found, to varying degrees, within all areas of ectopic
cartilage (Fig. 6d and Supplementary Fig. 7c), and these included
Tomþ cells that had transiently proliferated following injury
(Fig. 6d). The mosaic pattern of reporter expression in the newly
formed cartilage-like tissues in vivo (Supplementary Fig. 7b,c), as
well as the lack of reporter expression in chondrogenically
induced Tom sorted cells derived from Gdf5-Cre;Tom mice
(Fig. 7c) suggests that Tom expression was not induced de novo.
These ﬁndings demonstrate that the Gdf5 lineage in adult
synovium contains chondroprogenitors able to give rise to a
cartilage-like tissue in the joint in vivo.
Contribution to cartilage repair is Yap dependent. Having
shown that Yap is required in Gdf5-lineage cells for the synovial
lining hyperplasia secondary to joint surface injury (Fig. 5),
we analysed the repair tissue in Yap1 cKO and Yap1 cHa mice
8 weeks after cartilage injury (Fig. 6e). Strikingly, we detected
fewer Tomþ cells in the repair tissue in Yap1 cKO mice
compared to Yap1 cHa controls (Fig. 6f; 14.9±8.0% (mean±s.d.,
n¼ 4) of total cells in Yap1 cKO versus 53.1±23.9% (mean±s.d.,
n¼ 3) in Yap1 cHa mice). Cartilage-like repair tissue consisting
largely of Tom cells was observed (Fig. 6g), consistent with the
occasional presence of Tom chondrocyte-like cells in the repair
tissue of Gdf5-Cre;Tom mice (Supplementary Fig. 7b). Notwith-
standing, Tomþ chondrocyte-like cells were detected in the
repair tissue (Fig. 6h). Of note, results from Yap1 cHa mice
(Fig. 6f) were similar to those from Gdf5-Cre;Tom mice carrying
wild-type Yap1 described above (Fig. 6c). Taken together, these
ﬁndings demonstrate that absence of Yap in Gdf5-lineage cells
impairs their ability to populate the cartilage injury site.
Gdf5-lineage cells retain progenitor activity in vitro. We then
sought to investigate cell patterning and differentiation ability of
culture-expanded cells (Fig. 7a). A synovial organoid culture
model22 was used to assess the ability of cells to undergo
synoviogenesis. Tomþ cells consistently self-organized into a
lining layer of cells staining for the FLS marker cadherin-11
(Cdh11), reminiscent of the in vivo synovial lining, while
Tom cells lacked this ability (Fig. 7b).
Assessing chondrogenic ability showed Tomþ cells to give rise
to a cartilage-like matrix that more intensely stained for toluidine
blue (TB) and Col2 compared with Tom pellets (Fig. 7c). This
prompted us to investigate the stability of the in vitro-induced
cartilage-like phenotype using a subcutaneous implant model
(Fig. 7a). After 4 weeks, 13 out of 17 Tomþ (76%) and 2 out of 12
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Figure 4 | Yap is upregulated in the synovium of mice after injury and expressed in hyperplastic lining of human synovium. (a) Yap (brown) expression
in synovium of mice 4 days after cartilage injury (n¼4). Nuclei were counterstained with haematoxylin (blue). Boxed area on left is shown at higher
magniﬁcation on right. Scale bars, 20mm. (b–f) YAP expression in human synovium from (b) intra-articular fracture patients (n¼ 3 donors),
(c,e,f) osteoarthritis patients (n¼ 7 donors) and (d) normal knee synovium (n¼ 1 donor). (b–d) IHC for YAP (brown) showing hyperplastic versus
non-hyperplastic lining analysed within the same histological sections. Nuclei were counterstained with haematoxylin (blue). Boxed area on left is shown at
higher magniﬁcation on right. Scale bars, 20mm. (e) IF staining for YAP (red) and Ki67 (green). Nuclei were counterstained with DAPI (blue). Arrows
indicate double-positive cells. Scale bars, 10mm. (f) IF staining for YAP (blue) together with CD55 (red) marking synovial lining ﬁbroblasts and CD68
(green) marking macrophages. Nuclei were counterstained with DAPI (grey). Scale bar, 10mm.
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Tom pellets (17%) were recovered. The low retrieval rate of
Tom pellets suggested susceptibility to in vivo resorption.
Of the pellets analysed by histology, seven out of seven pellets
(from three donors) had retained Col2 expression in vivo with
ﬁve out of seven pellets also showing TB metachromasia (Fig. 7d),
while one out of two Tom pellets retrieved showed Col2 and TB
positivity. These data indicate the ability of adult Gdf5-lineage
cells to give rise to a stable cartilage-like tissue in vitro.
We also transplanted Tomþ cells orthotopically into cartilage
defects in 8-week-old C57Bl/6 wild-type mice (Fig. 7a), which
normally do not heal after cartilage injury23. After 4 weeks,
Tomþ cells were found in 7 out of 11 transplanted mice
embedded in a repair tissue ﬁlling the original defect, which in
ﬁve mice stained for Col2 (Fig. 7e), providing proof-of-concept
for the ability of culture-expanded Gdf5-lineage cells to contribute
to articular cartilage repair.
Tomþ cells did not display osteogenic activity in vitro,
while Tom cells from the same mice within the same
experiments were osteogenic to varying degrees (Fig. 7f).
Assessment of three Tomþ clonal populations derived by
single-cell sorting showed all clonal populations, even after the
extensive culture expansion required, to be synoviogenic, with
one clonal population also displaying chondrogenesis and
adipogenesis (Fig. 7g), pointing to a single-cell inherent multi-
potency within the Gdf5 lineage.
Joint morphogenetic properties of adult human synovial MSCs.
Finally, we extended our investigation to MSCs from adult
human synovium1. Culture-expanded cells from human syno-
vium (but not dermal ﬁbroblasts) display ability to undergo
synoviogenesis in vitro24, indicating their functional equivalence
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Figure 5 | Conditional knockout of Yap1 in Gdf5-lineage cells prevents synovial lining hyperplasia after cartilage injury. (a) H&E-stained sections of
knees from an adult Gdf5-Cre;Yap1ﬂ/ﬂ;Tom (Yap1 cKO) mouse and littermate control. P, patella; F, femur; T, tibia. Scale bars, 500mm. (b) Lack of Yap (green)
expression by Tomþ (red) synovial cells from adult Yap1 cKO mice (arrows) indicating successful Cre-mediated Yap1 KO in Gdf5-lineage cells (n¼ 3).
Nuclei were counterstained with DAPI (blue). Scale bars, 20mm. (c,d) CFU-f activity of synovial cells isolated from control (ctl), Yap1 haploinsufﬁcient
Gdf5-Cre;Yap1ﬂ/WT;Tom (Yap1 cHa) and Yap1 cKO mice showing (c) percentage of colonies (Z8 cells, that is, Z3 population doublings) that were Tomþ ,
and (d) percentage of Tomþ colonies that were large (Z64 cells, that is, Z6 population doublings) in ctl, Yap1 cHa and Yap1 cKO cultures (*Po0.05;
**Po0.01; n¼4; one-way ANOVA with Bonferroni post-test). (e) Normal and injured knee synovium of ctl, Yap1 cHa and Yap1 cKO mice 6 days after
cartilage injury. Top: H&E-stained sections. Bottom: Tom-stained (red) sections with DAPI (blue) counterstain. S, synovium; L, synovial lining; SL, synovial
sub-lining; C, capsule; F, femur. Scale bars, 50mm (H&E images) and 20mm (ﬂuorescent images). (f,g) Average number of cells per section in the synovial
lining (f), and sub-lining (g), quantiﬁed from H&E images as in e, showing decreased cellularity in synovial lining but not sub-lining of injured cHa and cKO
mice compared to ctl mice (**Po0.01; ***Po0.001; n¼4–6; two-way ANOVAwith Bonferroni post-test). (h) Yap1 cKO mice showed diminished expansion
of Tomþ Gdf5-lineage cells in synovium after cartilage injury (*Po0.05; ***Po0.001; n¼4–6; two-way ANOVA with Bonferroni post-test).
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to the mouse synovial Gdf5-lineage cells. Consistent with such
a notion, we observed during culture expansion of unsorted
synovial cells from Gdf5-Cre;Tom mice that Tomþ Gdf5-lineage
cells outgrew Tom cells within several passages (Supplementary
Fig. 8). Here we investigated the differentiation and patterning
capability of human synovial MSCs during endochondral
ossiﬁcation induced by bone morphogenetic protein (BMP)
signalling25. We adenovirally transduced culture-expanded
human synovial MSCs to overexpress Bmp7, and 4 days later
injected them into the posterior compartment of the thigh
in a nude mouse model26. Surprisingly, after 4 weeks we retrieved
an implant that histologically resembled a rudimentary joint, with
the two articulating sides each consisting symmetrically of
articular cartilage, subchondral bone containing marrow
and growth plate (Fig. 8a,b). Injection of untransduced cells
resulted in no retrievable implant, while injection of human
dermal ﬁbroblasts transduced with Ad-Bmp7 resulted in the
formation of an ossicle consisting of a perimeter of cortical bone
with trabeculae and a cavity containing fatty marrow, with
residual cartilage remnants (Fig. 8c), similar to the previously
reported ossicle formed after intramuscular implantation of
Ad-BMP7 mixed with demineralized bovine bone powder27.
In situ hybridization (ISH) for human-speciﬁc ALU genomic
repeats showed the persistence of human cells in the joint-like
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structure, with human nuclei detected in the articular cartilage
and subchondral bone, but negligibly in the growth plate
(Fig. 8d), while only sparse human nuclei were detected in
cartilage remnants and bone of the implant obtained with
dermal ﬁbroblasts (Fig. 8e). RT–PCR analysis of the implants
using species-speciﬁc primers revealed that while both implants
were in large part host-derived, expression of human ACAN
(aggrecan), Prg4 (lubricin) and BGLAP (osteocalcin), but not
COL10A1 (collagen type X), was detectable in the joint-like
structure obtained with human synovial MSCs (Fig. 8f and
Supplementary Fig. 9), conﬁrming the data obtained by ISH.
These ﬁndings show that the combination of an adult synovial
MSC population with one morphogen regulating endochondral
ossiﬁcation is sufﬁcient, after ectopic implantation into
skeletal muscle, to reproduce a joint-like structure, and provide
proof-of-concept that synovial MSCs retain morphogenetic
properties in adult life.
Discussion
Our study provides evidence for the existence of an ontogeneti-
cally deﬁned progenitor cell population purposely functional
in the synovial joint and distinct from hitherto reported
MSC populations, thereby adding another critical tile to the
emerging mosaic of the diversity of the stem/progenitor cells that
maintain and repair skeletal tissues in adult life.
We took advantage of a mouse strain with healing capacity to
show that the majority of cells contributing to articular cartilage
repair are of Gdf5 lineage. We detected Gdf5-lineage cells in adult
synovium, subchondral bone marrow and articular cartilage, and
any of these tissues could harbour the cartilage-repairing cells.
Articular cartilage is known to contain cells with chondropro-
genitor activity28–30. In addition, full-thickness joint surface
defects provide access for marrow cells to the injury.
Notwithstanding this, the contribution of Gdf5-lineage cells
to ectopic cartilage formation in synovium points to
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Figure 7 | Cell patterning and differentiation capacity of culture-expanded Gdf5-lineage cells. (a) Schematic experimental overview. (b) Tomþ cells
(n¼4 donor mice), but not Tom cells (n¼ 3 donor mice), formed a synovial-like structure with elongated, ﬂattened cells at the matrix-media interface
staining for Cdh11. Top and middle: H&E-stained sections; bottom: IF staining for Cdh11 (green) with DAPI counterstain (blue). (c,d) Cartilage pellets of
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mice (seven pellets of cells from three donor mice; pooled data from two experiments). Top: TB staining. Bottom: Col2 (green) and Tom (red) IF, with DAPI
counterstain in blue. Tomþ cells gave rise to a matrix that stained for TB and Col2, resistant to in vivo remodelling. (e) Contribution of transplanted Tomþ
cells to cartilage repair in non-healer C57Bl/6 mice (n¼ 11). Left: Cryosection showing Tomþ (red) cells at the cartilage defect. Right: Higher magniﬁcation
of black-boxed area on left after immunostaining for Col2 (green) with DAPI counterstain (blue). Shown is an overlay of two confocal images at different z
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chondroprogenitor activity in Gdf5-lineage cells in synovium.
Gdf5-lineage cells were mainly present in the synovial lining
where they included lubricin (Prg4)-expressing FLS. We also
observed a population of Gdf5-lineage cells not staining
for lubricin in the sub-lining tissue. Tracing of Prg4þ synovial
lining cells suggested that most synoviocyte progenitors in
1-month-old mice do not express Prg4 (ref. 30). Altogether,
this indicates that the sub-lining tissue is a putative progenitor
niche for FLS. In addition, following injury, Gdf5-lineage cells in
the sub-lining were recruited into a periarteriolar Nes-GFPbright
population, which co-expressed CD105 and SM22 indicating
a transition into myoﬁbroblasts and smooth muscle cells31,
possibly to support vasculogenesis.
Similar to Grem1 OCR stem cells11, Gdf5-lineage cells showed
little overlap with perisinusoidal MSCs, and contribute both
to skeletal development and to homoeostasis and repair.
While we detected rare Grem1þ cells in adult synovium that
showed no detectable overlap with the Gdf5-lineage population,
the nature of the Grem1þ cells in synovium and whether
these cells contain OCR stem cell activity similar to their
counterparts in bone marrow, remain to be determined.
It is not known whether distinct stem cell populations in
adult skeletal tissues co-exist. Chan et al.32 proposed a model
whereby skeletogenesis proceeds through a hierarchy of
lineage-restricted progenitors, and one primitive skeletal
stem cell gives rise to the cartilage, bone and stromal lineages,
with differential expression of a combination of cell surface
markers deﬁning distinct stages of lineage commitment. While
several of the key markers proposed (AlphaV, Thy1.1, CD105 and
CD200)32, and markers such as Pdgfra and Sca1 which identify
MSCs in mouse bone marrow4,5, were expressed by Gdf5-lineage
cells, we would interpret this as underscoring the dilemma of the
tissue-dependent phenotypic identity of the MSCs and their
poorly deﬁned relationship with the ﬁbroblasts, as for example
Pdgfra is considered a pan-ﬁbroblast marker in skin33.
Our ﬁndings indicate that Yap, a master regulator of gene
transcriptional networks modulating stem cell activity and organ
size34, is dispensable in Gdf5-lineage cells for joint development
and postnatal maintenance, but is required for their expansion
underpinning synovial lining hyperplasia and their efﬁcient
population of the repair tissue following joint surface injury.
The decreased contribution of Gdf5-lineage cells to cartilage
repair in Yap1 cKO mice may be due to an impaired recruitment
to the injury site, as a role for Yap in cell migration has been
reported35,36, or an impaired cell proliferation, in keeping with
our ﬁndings in the synovial lining. Of clinical relevance, Yap was
expressed by FLS in hyperplastic synovial lining from patients
with intra-articular fracture or osteoarthritis, although analysis of
a larger number of patient samples will be needed for further
validation and correlation with patient demographics and disease
status.
In developing limbs, the Gdf5-expressing JI cells constitute a
progenitor cell cohort endowed with joint formation and
patterning capacity37, with the spatiotemporal dynamics of
Gdf5 expression possibly instructing lineage divergence38. Our
study shows that Gdf5-lineage cells in adult synovium retain joint
progenitor activity. Moreover, we found that intramuscular
injection of adult human synovial MSCs overexpressing Bmp7
resulted in the formation of an ectopic joint-like structure, raising
the fascinating prospect that these cells carry an imprinted code
for joint morphogenesis. While BMP ligand speciﬁcity for
inducing this morphogenetic process remains to be determined,
it is intriguing to note that Bmp7 during embryonic development
is highly expressed in the perichondrium with characteristic
interruption at the JI39. We speculate that cells that are
progeny of the JI would deﬁne boundaries that steer the
cascade of BMP-induced endochondral ossiﬁcation into a joint
morphogenetic process.
Our study highlights the importance of cell-lineage tracing
experiments from deﬁned developmental structures to identify, in
adult tissues and organs, morphogenetic cell populations with the
prospect of utilizing them for studies of organogenesis and
regenerative therapies. Cell-based replacement therapies are
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Figure 8 | Joint morphogenetic properties of adult human synovial
MSCs. (a,b,d,f) Human synovial MSCs (n¼ 1) transduced with Ad-Bmp7
and injected into nude mouse thigh formed a joint-like structure upon
explant 4 weeks later, while (c,e,f) dermal ﬁbroblasts (n¼ 1) transduced
with Ad-Bmp7 gave rise to an ossicle. (d,e) ISH for human-speciﬁc ALU
genomic repeats. Black dots indicate human nuclei. Scale bars, 100 mm.
Boxed areas on left shown at higher magniﬁcation on right. SM: synovial
MSCs; DF: dermal ﬁbroblasts; H&E: haematoxylin and eosin; Tol blue:
toluidine blue; hALU: human ALU repeats. (f) RT–PCR analysis using
species-speciﬁc primers. Human positive controls (human ctl) were freshly
isolated chondrocytes from articular cartilage for ACAN (aggrecan) and
PRG4 (lubricin), MSCs treated with vitamin D3 for BGLAP (osteocalcin),
and bone marrow MSCs treated with TGFb1 in pellet culture for COL10A1
(collagen type X); a mouse knee joint was used as mouse ctl for all genes. h:
primer pair speciﬁc for human; m: primer pair speciﬁc for mouse; mh:
primer pair detects both mouse and human. Samples were equalized for
h-ACTB (h-b-actin; human ctl used for h-ACAN and h-PRG4 is shown), or
for mh-Actb in the case of the mouse ctl. See also Supplementary Fig. 9.
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promising for degenerative conditions such as osteoarthritis, the
commonest joint disease characterized by progressive loss of the
articular cartilage. Our ﬁndings provide a scientiﬁc rationale to
put forward cells from the adult synovium for joint surface
regeneration and treatment of osteoarthritis.
Methods
Mice and in vivo procedures. Gdf5-Cre mice (Tg(Gdf5-cre-ALPP)1Kng)14
were donated by Dr David Kingsley (Stanford, CA, USA). Nes-GFP mice
(Tg(Nes-EGFP)33Enik)40 were kindly provided by Dr Cristina Lo Celso
(Imperial College London, UK), with permission from Dr Grigori Enikolopov
(Cold Spring Harbor Laboratory, NY, USA). LepR-Cre (Leprtm3(cre)Mgmj) mice
that express Cre in cells expressing the long isoform of the leptin receptor
(LepRb)41 were kindly provided by Dr Lora Heisler (University of Aberdeen).
Yap1ﬂ mice (Yap1tm1.1Fcam)42 were provided by Dr Fernando Camargo
(Harvard, MA, USA). Cre-inducible tdTomato (Tom) (B6.Cg-Gt(ROSA)
26Sortm14(CAG-tdTomato)Hze/J)43 reporter mice were obtained from The Jackson
Laboratory. Mouse breeding was undertaken at Charles River Laboratories, UK.
Gdf5-Cre mice were maintained on an FVB background, all other mice on a C57Bl/6
background. Genotyping was performed according to published protocols14,40 or as
recommended by The Jackson Laboratory or donating investigator. For analysis of
embryos, mice were timed mated, and the morning of vaginal plug detection was
designated day 0.5. At E14.5, pregnant dams were killed and embryos collected.
C57Bl/6 wild type and immunodeﬁcient BALB/c Foxn1nu/nu (nude) mice were
purchased from Charles River or Harlan Laboratories. Animal experiments were
performed at the University of Aberdeen’s animal facility, where mice were kept in a
temperature-controlled room on a 12:12 light-dark cycle and provided with ad
libitum food and water. Adult mice were analysed at 12–20 weeks of age. Both male
and female mice were used for experiments. Cartilage repair was analysed in female
mice only. In vivo imaging was performed using a Bruker MS FX Pro imager. To
detect Tomþ cells in the circulation, blood was withdrawn from the tail vein and
Tom ﬂuorescence detected on an LSRII ﬂow cytometer (BD Biosciences, Oxford,
UK).
Joint surface injury was performed by medial parapatellar arthrotomy as
previously described23. Brieﬂy, mice were anaesthetized and subjected to surgery
under a dissection microscope. An incision was made to open up the skin over the
knee joint area, followed by an incision along the medial side of the patellar
ligament and through the quadriceps muscle to aid patellar dislocation. The
patellar groove was exposed and a full cartilage thickness scratch along the length
of the groove was made using a 25 g needle. The patella was then re-located, and
the joint capsule/muscle and the skin were sutured separately. Quantiﬁcations of
synovial cells were carried out in the lateral compartment of the knee at the
femoropatellar junction. The contralateral leg served as internal uninjured control.
Sham-operated controls were not included as we have found little response to sham
surgery in the synovium of the lateral compartment of the knee in this model12,17.
Proliferating cells were detected by administration of IdU and/or CldU as
previously described12. For orthotopic cell transplantation, Tomþ sorted and
culture-expanded cells from four Gdf5-Cre;Tom mice were pooled and 2 105 cells
in 1 ml PBS were applied to the cartilage defect using a Hamilton syringe
(Hamilton, Bonaduz, Switzerland) before closing the joint.
Animal experiments were approved by the UK Home Ofﬁce and the Animal
Welfare and Ethical Review Committee of the University of Aberdeen or the
KU Leuven Ethical Committee for Animal Research. Animal experiments were
performed in compliance with the 3Rs.
Human tissues. Human synovial tissue samples were obtained after informed
consent, with ethical approval from the NHS Grampian Biorepository. Synovial
samples were obtained from seven patients with osteoarthritis (three males, four
females; 50–81 years old) undergoing knee (six) or hip (one) joint arthroplasty,
three patients with intra-articular fractures undergoing fracture ﬁxation surgery
at 2–8 days following injury (two males, one female; 20–80 years old; two
glenohumeral joint fractures, one radial head fracture), and a patient (male adult)
undergoing knee joint excision for malignancy at a site not involving the
sampled area.
Histology and immunostainings. Samples for histology were ﬁxed in 4%
methanol-free paraformaldehyde (PFA; TAAB, Reading, UK) overnight, and
decalciﬁed in 4–10% EDTA (WVR Chemicals, Leuven, Belgium) for 2 weeks at
4 C. For cryoembedding, samples were incubated in 15% sucrose (Sigma) for 1 h
followed by 30% sucrose overnight at 4 C, then snap-frozen in optimum cutting
temperature (OCT) reagent (VWR Chemicals) over liquid nitrogen, and cut into
8 mm-thick sections using a cryostat (Leica Microsystems Ltd, Milton Keynes, UK).
For parafﬁn embedding, samples were dehydrated, embedded in parafﬁn and cut
into 5 mm-thick sections using a microtome (Leica Microsystems Ltd). Adult knee
joints were embedded ﬂexed as previously described23. Sections were rehydrated
and stained with haematoxylin and eosin (H&E, WVR Chemicals), TB (HoverLabs,
Haryana, India) or safranin O and fast green (Sigma), according to standard
protocols.
Immunohistochemistry (IHC) and IF stainings were performed as previously
described12. For cryosections, antigen retrieval was performed by incubation in
1% sodium dodecyl sulfate (Fisher Scientiﬁc) in PBS for 5min. Primary antibodies
used are listed in Supplementary Table 1. Sections were counterstained with
haematoxylin for IHC, or 40,6-diamidino-2-phenylindole (DAPI; Life technologies,
Eugene, OR, USA) for IF. IHC sections were analysed using an Imager Axioskop 40
microscope (Carl Zeiss Ltd, Cambridge, UK) with ProgRes C14 camera and
ProgRes CapturePro 2.8.8 software (JenOptik, Jena, Germany). IF sections were
analysed on a Zeiss 700 or 710 META Laser-Scanning Confocal Microscope with
ZEN software (Carl Zeiss Ltd), and transmitted light was captured to deﬁne the
area of synovium. Some sections were tile-scanned on a Zeiss Axioscan Z1 slide
scanner (Carl Zeiss Ltd). Image analysis and cell counting were performed using
ZEN2010 (Carl Zeiss Ltd) and ImageJ software. For quantiﬁcation of labelled cells
in histological sections, 2–11 sections per knee joint were analysed, and the total
number of counted cells determined.
Phenotyping and sorting of mouse synovial cells. Isolation of synovial cells
from mouse knee joints was performed by digestion with 1mgml 1 collagenase
type IV (Sigma) in normal growth media (high-glucose DMEM (Lonza, Verviers,
Belgium) with 10% foetal bovine serum (FBS; ThermoFisher Scientiﬁc, Renfrew,
UK), and 100 units ml 1 of penicillin and 0.1mgml 1 streptomycin (Sigma)) for
50min at 37 C under agitation, according to a protocol optimized for synovial cell
isolation44. Cells were released by vigorous vortexing, and cell suspensions passed
through a 40 mm cell strainer (Fisher Scientiﬁc, Loughborough, UK). Cells were
seeded at 5,000 cells cm 2 and grown in Mouse Mesencult Proliferation kit
(StemCell Technologies, Cambridge, UK) with penicillin/streptomycin and
2mM L-glutamine (Sigma) until cultures were established, then cultured in
regular growth media.
Freshly isolated cells were stained in 2mM EDTA in PBS with 0.5% FBS in
96-well conical bottom plates with ﬁxable viability dye eFluor780 (eBiosciences,
Hatﬁeld, UK) and antibodies listed in Supplementary Table 2. Data were acquired
on an LSRII ﬂow cytometer and analysed using FlowJo v10 software (Ashland, OR,
USA). Unstained and single-labelled cells or antibody-labelled CompBeads
(BD Biosciences) were used to set compensation and gates were applied based on
ﬂuorescence-minus-one controls. To identify single live cells within fresh cell
isolates, erythrocytes and debris were gated out based on forward-side scatter
proﬁle, then doublets and aggregates were gated out based on forward scatter
parameters, and ﬁnally dead cells were excluded based on viability dye staining
(see Supplementary Fig. 2).
Sorting was performed on an Inﬂux Cell Sorter (BD Biosciences). Erythrocytes
and debris were excluded based on forward and side scatter proﬁle, and cells
were sorted based on Tom ﬂuorescence, and in one experiment, CD45 and
Pdgfra IF staining. Small aliquots of sorted cells were analysed on an LSRII ﬂow
cytometer immediately after sorting to determine purity. For derivation of clonal
cell populations, Tomþ cells were directly sorted into a 96-well plate. After 12 days
of culture, eight wells were identiﬁed that contained a single colony, and three
clones continued to expand and were used to assess potency at the single-cell level.
CFU-f and potency assays. For CFU-f activity, cells were seeded in 24-well plates
in 4–8 replicate wells using Mouse Mesencult Proliferation kit with penicillin/
streptomycin and 2mM L-glutamine at clonal seeding densities as established
in pilot experiments. After 8 days, colonies were analysed on an Observer
Z1 ﬂuorescence microscope using AxioVision 4.8.20 software (Carl Zeiss Ltd).
Synovial organoid cultures (250,000 cells per organoid) were established as
described22, and after 21 days, ﬁxed in 1% PFA, cryoembedded and sectioned for
histological analysis. Chondrogenesis was induced by treatment with TGFb1
(Gibco) in pellet culture (500,000 cells per pellet) for 21 days in serum-free DMEM
with ITS-G (Gibco) supplemented with BSA (Sigma) and linoleic acid (Sigma),
0.1 mM dexamethasone and 50mgml 1 2-phospho-L-ascorbic acid trisodium salt
(Sigma). To assess stability, chondrogenic cell pellets were implanted in
subcutaneous pouches (up to four per mouse) of 11-week-old female nude mice,
and after 4 weeks retrieved post-mortem under a stereomicroscope45. Pellets were
embedded in parafﬁn and evaluated histologically and by IF staining. Pellets from
cells that failed to show in vitro chondrogenesis were excluded from analysis post-
implant. For osteogenic differentiation, cells seeded at 4–5 104 cells cm 2 in 24-
or 48-well plates were treated for 21 days with osteogenic media consisting of either
a-MEM (Sigma) with 10% FBS and penicillin/streptomycin supplemented with
5mM b-glycerophosphate disodium salt hydrate (Sigma) and 50 mgml 1
2-phospho-L-ascorbic acid trisodium salt (Sigma), or MesenCult mouse osteogenic
stimulatory kit (StemCell Technologies). Osteogenesis was detected by staining
with Alizarin red S (Sigma). For adipogenic differentiation, cells seeded at 5 104
cells cm 2 in 48-well plates were treated for 21 days with adipogenic media
consisting of Mesencult media supplemented with 500 mM dexamethasone,
10 mgml 1 insulin (Sigma) and 10 mM indomethacin (Sigma). Adipocytes were
detected by staining with Oil red O and cresyl violet (Sigma). Control wells
received media without supplements.
Mouse AR angiogenesis assay was performed as described46. Brieﬂy, ARsB0.5
mm in width from an 8-week-old C57Bl/6 mouse were incubated overnight in
Opti-MEM with GlutaMAX-I (Gibco) with penicillin/streptomycin for serum
starvation. Next day, ARs were embedded in growth factor-reduced Matrigel
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(Corning) mixed with 3,000 culture-expanded Gdf5-Cre;Tom;Nes-GFP mouse knee
joint cells and cultured in Opti-MEM with penicillin/streptomycin supplemented
with 5% FBS and 30 ngml 1 VEGF (Peprotech) for 7 days, changing the medium
every 2–3 days. Samples were ﬁxed in 1% PFA, counterstained with DAPI and
analysed on a Zeiss 710 META laser-scanning confocal microscope.
Ectopic joint morphogenesis. Adult human synovial MSCs1 at p9 or human
dermal ﬁbroblasts1 at p10 were transduced with pACCMVpLpA adenovirus
encoding mouse Bmp7 at 20 multiplicity of infection (MOI) and 4 days later
5 106 transduced cells were injected into the quadriceps muscle of a nude
mouse26. Implants were analysed after 4 weeks histologically, by RT–PCR and ISH
for human ALU genomic repeats.
Gene expression analysis. RNA was extracted from cells or tissues using either
a standard TRIzol/chloroform extraction protocol, or a ReliaPrep RNA tissue
Miniprep kit (Promega, Southampton, UK). Total RNA was reverse transcribed to
cDNA. Expression of genes was determined by quantitative PCR (qPCR) using
SYBR Green Master (Roche, Basel, Switzerland) on a LightCycler480 (Roche), as
previously described20, and data were normalized to expression of Gapdh.
Detection of species-speciﬁc gene expression was carried out by semi-quantitative
RT–PCR. Primer sequences are listed in Supplementary Table 3.
ISH for human ALU genomic repeats. ISH for human ALU genomic repeats was
performed as described elsewhere26. Brieﬂy, sections were deparafﬁnized and
rehydrated. Matrix digestion was obtained by enzymatic treatment with
10mgml 1 proteinase K in 0.1M Tris-HCl, 50mM EDTA, pH 8, for 30min at
37 C. Sections were immediately post ﬁxed in 3% formaldehyde for 10min,
washed in PBS, dehydrated in an ethanol series and dried for 20min at room
temperature. After rehydration and equilibration in PBS, sections were acetylated
in 0.25% acetic acid containing 0.1M triethanolamine (pH 8) for 10min, and
pre-hybridized with 50% deionized formamide containing 4 SSC at 37 C for
15min. Sections were covered with hybridization buffer (1 Denhardt’s solution,
0.2mgml 1 denatured sheared salmon sperm DNA, 4 SSC and 50% deionized
formamide) containing 1 ng ml 1 digoxigenin-labelled double-stranded DNA
probe speciﬁc for human ALU genomic repeats and covered with a glass coverslip.
Denaturation of both the probe and the genomic DNA template was achieved by
heating the slides at 95 C for 45 s. Hybridization was performed at 42 C
overnight. Sections were washed twice for 30min at room temperature with
2 SSC and 0.1 SSC and for 30min at 50 C in 0.1 SSC. Digoxigenin was
detected using a commercially available kit (DIG Nucleic Acid Detection Kit,
Sigma) according to the manufacturer’s protocol.
Statistical analysis. Statistical analysis was performed using GraphPad Prism v5
software. Data in graphs are shown as data points of individual mice, with lines
indicating mean. Data in text are given as mean±s.d. The n-number refers to
number of mice unless otherwise stated. Mice that showed an unusual degree of
transgene expression were excluded mostly a priori (Supplementary Fig. 1a–c) and
occasionally at the analysis stage. Group assignment was based on genotype,
therefore, no randomization was carried out. Sample size was estimated based on
previous data where appropriate12,23. The researchers involved in the study were
not completely blinded during sample collection or data analysis. For comparison
of two groups, data were analysed by two-tailed unpaired Student’s t-test, with or
without Welch’s correction for unequal variances, or by two-tailed Mann–Whitney
test. One-way ANOVA with Bonferroni post-test was used for comparison
of Z3 groups, or two-way ANOVA with Bonferroni post-test for comparisons
across two variables. A P-value r0.05 was considered statistically signiﬁcant.
Data availability. All data supporting the ﬁndings of this study are available
within the article and its Supplementary Information ﬁles, or are available from the
corresponding author on reasonable request.
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